NEW YORK (GenomeWeb News) – Of the 33 firms that are included in the GenomeWeb Daily News Index of life science tools and molecular diagnostics makers, eight of those had stock price gains exceeding 100 percent for full-year 2009.

As was the case with tech stocks in general in the market, many of the firms in the Index had double-digit returns, with only six firms having a drop in their stock price compared to the close of 2008.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: rare variants linked to bleeding disorder, comparison of whole-exome and whole-genome sequencing, and more.

George Church tells The Sunday Times that his group has inserted some woolly mammoth genes into elephant cells.

A Scientific Reports editor resigns over a new policy at the journal allowing researchers to pay to fast track the peer review of their manuscripts, and poll.

The National Cancer Institute's Harold Varmus discusses the state of cancer research with the New York Times.